SlideShare a Scribd company logo
Dr Lola Ramachandran
Professor
JMMCH & RI
 1% of all pregnancies
 One of the leading indirect causes of
maternal mortality
 Increase in cardiac output by 40%
 Incr in stroke vol by 10%
 Incr in heart rate by 10% (15 bpm)
 Incr in blood volume by 40%
 Decrease in peripheral resistance & diastolic BP
 Rheumatic - more in dev countries, 90% MS
 Congenital – ASD commonest
 Progressive dyspnoea
 Orthopnoea
 Paroxysmal nocturnal dyspnoea
 Hemoptysis
 Palpitations
 Syncope
 Nocturnal cough
 Chest pain
 Cynosis
 Clubbing
 Persistent distension neck veins
 Thrill
 Parasternal heave
 Diastolic murmur
 A grade 3 systolic murmur
 AF, persistent arrythmias
 Cardiomegaly
 Persistent split 2nd sound, Loud P2
 Echocardiography
◦ Structural lesion,
◦ Valve area & severity
◦ Valve gradient
◦ Ventricular function
 Safe, non invasive
 ECG diagnoses arrythmias only
 Collapsing pulse – wide pulse pressure in preg
 Increase in HR, ectopic beats
 JVP waves more prominent
 Heart size increases
 Apex beat displaced up & laterally
 Loud S1,third heart sound
 Ejection systolic murmurs(gr 2 & 3)
 Venous hums in neck & mammary souffle ov breast
 Peripheral edema
 ECG – left axis deviation, mild ST changes
NYHA Classification
Class I Uncompromised/no limitation in physical activity
Class
II
Slight limitation of physical activity/dyspnoea on severe
exertion
Class
III
Marked limitation of physical activity/dyspnoea on mild exertion
Class
IV
Severely compromised/Dyspnoea at rest
 Myocardial dysfunction(Ejection fraction <40% or
cardiomyopathy)
 Prior heart failure, arrythmia or stroke
 Previous arrythmia needing treatment
 NYHA class 3 or 4 or cyanosis
 L sided obstruction(mitral area <2sq.cm/peak LV
outflow tract gradient above 30mm Hg/Aortic valve
<1.5sq cm)
 Based on risk stratification
 Given intrapartum to women at high &
moderate risk only in presence of suspected
bacteremia or active infection
 Optional in women at high risk undergoing
uncomplicated delivery & not for mod risk gp
High risk Moderate risk
Prosthetic valves Most other congenital cardiac
malformations
Previous endocarditis Rheumatic valvular heart disease
Complex cyanotic heart disease Hypertrophic cardiomyopathy
Surgically constructed shunts or
conduits
Mitral valve prolapse with
regurgitation or thickened leaflets
 Given 30 – 60 min before the procedure
 Ampicillin 2 g or cefazolin/ ceftriaxone 1gm IV
 If sensitive to penicillin, clindamycin 600mg IV
 Oral – 2gm amoxycillin
 Vancomycin also if enterococcus suspected
 Isolated atrium septum secondum
 Surgical repair of ASD, VSD & PDA
 Prev coronory bypass graft surgery
 Mitral valve prolapse without regurgitation
 Previous Kawasaki disease without valvular
dysfunction
 Cardiac pacemaker
 Eisenmenger syndrome
 Primary pulmonary hypertension
 Uncorrected severe coarctation
 Marfans with aorta dilated >45mm
 Severe MS with complications
 Severe symptomatic aortic stenosis
 Prev peripartum cardiomyopathy with residual
LV dysfunction
 Preconceptional counselling
 V imp in artificial valves on oral anticoagulants
 Cong lesions & MS better corrected surgically first
 Mild MS, complete family early
 Combined clinic, tertiary care centre, cardio+obst
 Two issues
◦ ?need for termination
◦ ? Need for surgery
◦ If surgery needed best in 2nd trimester
 Fetal surveillance with growth scans
 Mostly uneventful
 No need of early hospitalisation
 Physical activity to be kept within the pt’s cardiac
reserve
 Adequate rest, frequent follow ups
 Look out for nocturnal cough & persistent basal
crepitations  heart failure
 Sudden reduction in ability to carry out usual
duties and dyspnoea
 Prevent respiratory infections
 Antiobiotics at first sign of infection
 Look for asymptomatic bacteriuria & treat
 Dental hygiene
 Prevent anaemia
 Hypertension to be managed incr pre load
 Arrythmias to be treated
 Fetal echo especially in congenital heart
diseased pts
 Anaemia
 Tachycardia & arrythmias
 Hypertension
 Hyperthyroidism
 Multiple pregnancy
 Respiratory infections
 Stress
 At high risk
 Ideally should be pregnant only after surgical
correction
 If seen in 1st trimester  adv MTP
 If continuing preg, counsel regarding risks
 Hospitalised for the rest of the pregnancy
 Delivery in an experienced unit
 Vaginal delivery preferred except
◦ Coarctation of aorta
◦ Marfan’s with aortic diameter 45mm or more
 Spontaneous labour best
 EAS,Oxytocin, ARM if Cx favourable
 PGs theoretical risk of coronary vasospasm &
arrythmias
 Analgesia
 Position - semi recumbent
 Fluid management(not more than 75 ml/hr)
 Monitoring
◦ BP, Heart rate
◦ Pulse oxymetry
◦ Continuous ECG?arrythmias
 ? Swan Ganz catheter in some cases
 Continuous electronic fetal heart monitoring
 Outlet forceps
 Frusemide 40 mg IV soon after baby born
THIRD STAGE
Ergometrine & Methergin contra indicated
Oxytocin IV/IM can be used
 Can decompensate
 Observed in labour ward 48 hours
 Fluid balance to be monitored
 Look out for PPH, Infection & Thrombo embolism
 Thrombo prophylaxis with heparin
 Early ambulation
 Lactation
 Barrier preferred
 LNG IUS(MIRENA) safe & effective
 COCs not preferred in pts prone for
thrombosis(MS, Artificial valves)
 Progesterone injectables & Minipills may be
used but fluid retention problem
 Vasectomy for male partner
 Interval sterilisation GA, not laparoscopic
 Congestive cardiac failure
 Acute pulmonary edema
 Arrythmias
 Subacute bacterial endocarditis
 Previously, closed mitral valvotomy,
 Now, Balloon valvuloplasty, if valve pliable &
not calcified & minimal regurgitation
 Radiation exposure
 Safest time after 20 wks
Indications in pregnancy
1. Failure of medical T/T in intractable heart
failure
2. Recurrent episodes of ac pulmonary edema
Maternal
Factors affecting
 NYHA functional class
 Presence of pulmonary hypertension
 Cyanotic heart disease
 Type of lesion
 Fetal outcome
 Prematurity
 IUGR
 Risk of congenital heart disease
 Mitral stenosis
 90%
 Critical stenosis- valve area <1cm2(N=4cm2)
 Moderate stenosis – 1 – 2.5cm2
 Mortality high in NYHA class III & IV
L atrial presspulm HT ventricular failure,pulm
edema
 Cardiac surgery best before pregnancy
 Or balloon valvuloplasty after 20 wks
 Limited physical activity
 Na restricted, diuretics,β blockers
 If new onset atrial fibrillation – verapamil,electroversion
 Digoxin, β blockers for chr fibrillation
 If persistant fibrillation/L atrial thrombus –
heparin
 Vaginal delivery preferred
 Epidural analgesia, avoid overload
 Bacterial endocarditis prophylaxis
 Thromboembolism & infective endocarditis
 Warfarin safe for mother but embryopathy
◦ Chondrodysplasia punctata,
◦ Nasal hypoplasia
◦ Optic atrophy
◦ Microcephaly
◦ Miscarriage, IUGR, SB
 Discontinue warfarin at 6 wks
 In high risk,IV heparin infusion,low risk,SC heparin
 Restart warfarin at 14 wks
 34 – 36 wks – restart IV heparin infusion
 Labour to be planned
 Stop heparin 6 hrs before delivery
 Restart heparin 6 hrs after vaginal, 12 hrs after CS
 Start warfarin after 3days,withdraw heparin once
INR adjusted(safe in lactation)
 Infective endocarditis prophylaxis mandatory
 ASD,corrected VSD, PDA usually safe
 Eisenmenger syndrome – preg contraindicated
 Tetralogy of Fallot- high risk if uncorrected
 Coarctation of aorta – corrected,good prognosis
 Residual HT in 30%- risk of aortic dissection &
paroxysmal HT in 2ndstage rupture aneurysm,ICH
 Marfan’s – risk of aortic dissection & ao rupture
 Primary Pulm HT – preg contra indicated
 Cardiac failure in the last month of preg or within
5 mths foll delivery.
 Absence of another identifiable cause
 Absence of recognisable heart disease bef last
mth of preg
 ECHO – LV systolic dysfunction(EF <45%, M mode
fractional shortening < 30% & L V end diastolic
dimension > 2.7cm/m2
 Mat outcome not very good, pulm embolism,
cereb thrombosis
1. What is the intrapartum management of a
patient with heart disease in pregnancy?
2. Describe NYHA classification.
Heart disease in pregnancy

More Related Content

What's hot

CTG: patterns
CTG: patterns CTG: patterns
CTG: patterns
Aboubakr Elnashar
 
Obstructed labor and uterine rupture
Obstructed labor and uterine ruptureObstructed labor and uterine rupture
Obstructed labor and uterine rupture
AkeFid
 
Heart disease pregnancy new dr rabi
Heart disease pregnancy new dr rabiHeart disease pregnancy new dr rabi
Heart disease pregnancy new dr rabi
Rabi Satpathy
 
Vulvovaginal hematoma - Dr Mitra Saxena
Vulvovaginal hematoma  - Dr Mitra SaxenaVulvovaginal hematoma  - Dr Mitra Saxena
Vulvovaginal hematoma - Dr Mitra Saxena
SurekhaTayade4
 
Puerperal genital hematomas
Puerperal genital hematomasPuerperal genital hematomas
Puerperal genital hematomas
muhammad al hennawy
 
Hypertensive Disorders in Pregnancy Update April 2019
Hypertensive Disorders in Pregnancy Update April 2019Hypertensive Disorders in Pregnancy Update April 2019
Hypertensive Disorders in Pregnancy Update April 2019
Kervindran Mohanasundaram
 
Rupture uterus
Rupture uterusRupture uterus
Rupture uterus
muhammad al hennawy
 
cardiac disease in pregnancy
cardiac disease in pregnancycardiac disease in pregnancy
cardiac disease in pregnancy
Balkeej Sidhu
 
early pregnancy complications
early pregnancy complicationsearly pregnancy complications
early pregnancy complications
snich
 
Seminar heart diseases in preg
Seminar heart diseases in pregSeminar heart diseases in preg
Seminar heart diseases in preg
sunanda nimmalapudi
 
CTG when, why and how Osama Akl
CTG when, why and how Osama AklCTG when, why and how Osama Akl
CTG when, why and how Osama Akl
Osama Akl
 
Antepartum and intrapartum foetal monitoring
Antepartum and intrapartum foetal monitoringAntepartum and intrapartum foetal monitoring
Antepartum and intrapartum foetal monitoring
rajeev sood
 
Prom and pprom
Prom and ppromProm and pprom
Prom and pprom
animesh kunwar
 
Cardiotocography (CTG) warda
Cardiotocography (CTG) wardaCardiotocography (CTG) warda
Cardiotocography (CTG) warda
Osama Warda
 
Bleeding during pregnancy
Bleeding during pregnancyBleeding during pregnancy
Bleeding during pregnancy
Royal Medical Services
 
Classification of Heart Disease in Pregnancy
Classification of Heart Disease in PregnancyClassification of Heart Disease in Pregnancy
Classification of Heart Disease in Pregnancy
Chukwuma Onyeije, MD, FACOG
 
Pregnancy & cvd
Pregnancy & cvdPregnancy & cvd
Pregnancy & cvd
Anand Manjunath
 
Post menopausal bleeding seminar
Post menopausal bleeding seminarPost menopausal bleeding seminar
Post menopausal bleeding seminar
mohammed abdulbast
 
Cardiovascular Diseases on Pregnancy
Cardiovascular Diseases on PregnancyCardiovascular Diseases on Pregnancy
Cardiovascular Diseases on Pregnancy
pogisurabaya
 
CTG: Interpretation and management
CTG: Interpretation and management CTG: Interpretation and management
CTG: Interpretation and management
Aboubakr Elnashar
 

What's hot (20)

CTG: patterns
CTG: patterns CTG: patterns
CTG: patterns
 
Obstructed labor and uterine rupture
Obstructed labor and uterine ruptureObstructed labor and uterine rupture
Obstructed labor and uterine rupture
 
Heart disease pregnancy new dr rabi
Heart disease pregnancy new dr rabiHeart disease pregnancy new dr rabi
Heart disease pregnancy new dr rabi
 
Vulvovaginal hematoma - Dr Mitra Saxena
Vulvovaginal hematoma  - Dr Mitra SaxenaVulvovaginal hematoma  - Dr Mitra Saxena
Vulvovaginal hematoma - Dr Mitra Saxena
 
Puerperal genital hematomas
Puerperal genital hematomasPuerperal genital hematomas
Puerperal genital hematomas
 
Hypertensive Disorders in Pregnancy Update April 2019
Hypertensive Disorders in Pregnancy Update April 2019Hypertensive Disorders in Pregnancy Update April 2019
Hypertensive Disorders in Pregnancy Update April 2019
 
Rupture uterus
Rupture uterusRupture uterus
Rupture uterus
 
cardiac disease in pregnancy
cardiac disease in pregnancycardiac disease in pregnancy
cardiac disease in pregnancy
 
early pregnancy complications
early pregnancy complicationsearly pregnancy complications
early pregnancy complications
 
Seminar heart diseases in preg
Seminar heart diseases in pregSeminar heart diseases in preg
Seminar heart diseases in preg
 
CTG when, why and how Osama Akl
CTG when, why and how Osama AklCTG when, why and how Osama Akl
CTG when, why and how Osama Akl
 
Antepartum and intrapartum foetal monitoring
Antepartum and intrapartum foetal monitoringAntepartum and intrapartum foetal monitoring
Antepartum and intrapartum foetal monitoring
 
Prom and pprom
Prom and ppromProm and pprom
Prom and pprom
 
Cardiotocography (CTG) warda
Cardiotocography (CTG) wardaCardiotocography (CTG) warda
Cardiotocography (CTG) warda
 
Bleeding during pregnancy
Bleeding during pregnancyBleeding during pregnancy
Bleeding during pregnancy
 
Classification of Heart Disease in Pregnancy
Classification of Heart Disease in PregnancyClassification of Heart Disease in Pregnancy
Classification of Heart Disease in Pregnancy
 
Pregnancy & cvd
Pregnancy & cvdPregnancy & cvd
Pregnancy & cvd
 
Post menopausal bleeding seminar
Post menopausal bleeding seminarPost menopausal bleeding seminar
Post menopausal bleeding seminar
 
Cardiovascular Diseases on Pregnancy
Cardiovascular Diseases on PregnancyCardiovascular Diseases on Pregnancy
Cardiovascular Diseases on Pregnancy
 
CTG: Interpretation and management
CTG: Interpretation and management CTG: Interpretation and management
CTG: Interpretation and management
 

Similar to Heart disease in pregnancy

Cardiac diseases complicating pregnancy
Cardiac diseases  complicating pregnancyCardiac diseases  complicating pregnancy
Cardiac diseases complicating pregnancy
Arya Anish
 
Pregnancy and Heart Disease
Pregnancy and Heart DiseasePregnancy and Heart Disease
Cardiac diseases in pregnancy 30.7.2013
Cardiac diseases in pregnancy 30.7.2013Cardiac diseases in pregnancy 30.7.2013
Cardiac diseases in pregnancy 30.7.2013
limgengyan
 
HEART DISEASE & PREGNANCY.pptx
HEART DISEASE & PREGNANCY.pptxHEART DISEASE & PREGNANCY.pptx
Heart disease in pregnancy
Heart disease in pregnancyHeart disease in pregnancy
Heart disease in pregnancy
SanaJaved51
 
Heart disease in pregnancy
Heart disease in pregnancy Heart disease in pregnancy
Heart disease in pregnancy
Dato' Dr.Aruku Naidu O&G
 
Peripartum cardiomyopathy
Peripartum cardiomyopathyPeripartum cardiomyopathy
Peripartum cardiomyopathy
Anor Abidin
 
Pediatric Arrythmias
Pediatric ArrythmiasPediatric Arrythmias
Pediatric Arrythmias
Sonali Paradhi Mhatre
 
Primary PCI in rare occasions
Primary PCI in rare occasionsPrimary PCI in rare occasions
Primary PCI in rare occasions
Mohamed Ashraf
 
Cardiomyopathy by dr sajid.pptx
Cardiomyopathy by dr sajid.pptxCardiomyopathy by dr sajid.pptx
Cardiomyopathy by dr sajid.pptx
Movies4You1
 
Pulmonary embolism
Pulmonary embolismPulmonary embolism
Pulmonary embolism
Khurram Wazir
 
Cardiac diseases in pregnancy2
Cardiac diseases in pregnancy2Cardiac diseases in pregnancy2
Cardiac diseases in pregnancy2
Arya Anish
 
4 pregnancy complications
4 pregnancy complications4 pregnancy complications
4 pregnancy complications
obsgyna
 
Approach to Pediatric Cardiovascular diseases.pptx
Approach to Pediatric Cardiovascular diseases.pptxApproach to Pediatric Cardiovascular diseases.pptx
Approach to Pediatric Cardiovascular diseases.pptx
RaheelAhmed210939
 
Pregnancy and heart diseases PPT.pptx
Pregnancy and heart diseases PPT.pptxPregnancy and heart diseases PPT.pptx
Pregnancy and heart diseases PPT.pptx
Abhishek Sakwariya
 
Cardiac Diseases in Pregnancy pptx
Cardiac Diseases in Pregnancy pptxCardiac Diseases in Pregnancy pptx
Cardiac Diseases in Pregnancy pptx
Havillah medical center
 
Congenital Heart Diseases in Children.pptx
Congenital Heart Diseases in Children.pptxCongenital Heart Diseases in Children.pptx
Congenital Heart Diseases in Children.pptx
Ashik Alvee
 
Seminar on Congenital Heart Disease
Seminar on Congenital Heart DiseaseSeminar on Congenital Heart Disease
Seminar on Congenital Heart Disease
Soumen Sengupta
 
Pulmonary hypertension
Pulmonary hypertensionPulmonary hypertension
Pulmonary hypertension
vijay mundhe
 
complex medical disorders in pregnancy
 complex medical disorders in pregnancy  complex medical disorders in pregnancy
complex medical disorders in pregnancy
partha sarathi roy
 

Similar to Heart disease in pregnancy (20)

Cardiac diseases complicating pregnancy
Cardiac diseases  complicating pregnancyCardiac diseases  complicating pregnancy
Cardiac diseases complicating pregnancy
 
Pregnancy and Heart Disease
Pregnancy and Heart DiseasePregnancy and Heart Disease
Pregnancy and Heart Disease
 
Cardiac diseases in pregnancy 30.7.2013
Cardiac diseases in pregnancy 30.7.2013Cardiac diseases in pregnancy 30.7.2013
Cardiac diseases in pregnancy 30.7.2013
 
HEART DISEASE & PREGNANCY.pptx
HEART DISEASE & PREGNANCY.pptxHEART DISEASE & PREGNANCY.pptx
HEART DISEASE & PREGNANCY.pptx
 
Heart disease in pregnancy
Heart disease in pregnancyHeart disease in pregnancy
Heart disease in pregnancy
 
Heart disease in pregnancy
Heart disease in pregnancy Heart disease in pregnancy
Heart disease in pregnancy
 
Peripartum cardiomyopathy
Peripartum cardiomyopathyPeripartum cardiomyopathy
Peripartum cardiomyopathy
 
Pediatric Arrythmias
Pediatric ArrythmiasPediatric Arrythmias
Pediatric Arrythmias
 
Primary PCI in rare occasions
Primary PCI in rare occasionsPrimary PCI in rare occasions
Primary PCI in rare occasions
 
Cardiomyopathy by dr sajid.pptx
Cardiomyopathy by dr sajid.pptxCardiomyopathy by dr sajid.pptx
Cardiomyopathy by dr sajid.pptx
 
Pulmonary embolism
Pulmonary embolismPulmonary embolism
Pulmonary embolism
 
Cardiac diseases in pregnancy2
Cardiac diseases in pregnancy2Cardiac diseases in pregnancy2
Cardiac diseases in pregnancy2
 
4 pregnancy complications
4 pregnancy complications4 pregnancy complications
4 pregnancy complications
 
Approach to Pediatric Cardiovascular diseases.pptx
Approach to Pediatric Cardiovascular diseases.pptxApproach to Pediatric Cardiovascular diseases.pptx
Approach to Pediatric Cardiovascular diseases.pptx
 
Pregnancy and heart diseases PPT.pptx
Pregnancy and heart diseases PPT.pptxPregnancy and heart diseases PPT.pptx
Pregnancy and heart diseases PPT.pptx
 
Cardiac Diseases in Pregnancy pptx
Cardiac Diseases in Pregnancy pptxCardiac Diseases in Pregnancy pptx
Cardiac Diseases in Pregnancy pptx
 
Congenital Heart Diseases in Children.pptx
Congenital Heart Diseases in Children.pptxCongenital Heart Diseases in Children.pptx
Congenital Heart Diseases in Children.pptx
 
Seminar on Congenital Heart Disease
Seminar on Congenital Heart DiseaseSeminar on Congenital Heart Disease
Seminar on Congenital Heart Disease
 
Pulmonary hypertension
Pulmonary hypertensionPulmonary hypertension
Pulmonary hypertension
 
complex medical disorders in pregnancy
 complex medical disorders in pregnancy  complex medical disorders in pregnancy
complex medical disorders in pregnancy
 

Recently uploaded

June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan PatroJune 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
Kanhu Charan
 
SENSORY NEEDS B.SC. NURSING SEMESTER II.
SENSORY NEEDS B.SC. NURSING SEMESTER II.SENSORY NEEDS B.SC. NURSING SEMESTER II.
SENSORY NEEDS B.SC. NURSING SEMESTER II.
KULDEEP VYAS
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Jim Jacob Roy
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
Nano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory projectNano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory project
SIVAVINAYAKPK
 
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdfTest bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
rightmanforbloodline
 
Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024
Torstein Dalen-Lorentsen
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
Dr. Nikhilkumar Sakle
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
LEFLOT Jean-Louis
 
How to Control Your Asthma Tips by gokuldas hospital.
How to Control Your Asthma Tips by gokuldas hospital.How to Control Your Asthma Tips by gokuldas hospital.
How to Control Your Asthma Tips by gokuldas hospital.
Gokuldas Hospital
 
Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.
Kunj Vihari
 
DECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principlesDECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principles
anaghabharat01
 
10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations   10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
Traumasoft LLC
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...
Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...
Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...
AyushGadhvi1
 
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International TravelersTravel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
NX Healthcare
 
Recent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptxRecent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptx
DrGirishJHoogar
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
Skin Diseases That Happen During Summer.
 Skin Diseases That Happen During Summer. Skin Diseases That Happen During Summer.
Skin Diseases That Happen During Summer.
Gokuldas Hospital
 

Recently uploaded (20)

June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan PatroJune 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
 
SENSORY NEEDS B.SC. NURSING SEMESTER II.
SENSORY NEEDS B.SC. NURSING SEMESTER II.SENSORY NEEDS B.SC. NURSING SEMESTER II.
SENSORY NEEDS B.SC. NURSING SEMESTER II.
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
Nano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory projectNano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory project
 
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdfTest bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
 
Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
 
How to Control Your Asthma Tips by gokuldas hospital.
How to Control Your Asthma Tips by gokuldas hospital.How to Control Your Asthma Tips by gokuldas hospital.
How to Control Your Asthma Tips by gokuldas hospital.
 
Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.
 
DECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principlesDECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principles
 
10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations   10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...
Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...
Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...
 
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International TravelersTravel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
 
Recent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptxRecent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptx
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
Skin Diseases That Happen During Summer.
 Skin Diseases That Happen During Summer. Skin Diseases That Happen During Summer.
Skin Diseases That Happen During Summer.
 

Heart disease in pregnancy

  • 2.  1% of all pregnancies  One of the leading indirect causes of maternal mortality
  • 3.  Increase in cardiac output by 40%  Incr in stroke vol by 10%  Incr in heart rate by 10% (15 bpm)  Incr in blood volume by 40%  Decrease in peripheral resistance & diastolic BP
  • 4.  Rheumatic - more in dev countries, 90% MS  Congenital – ASD commonest
  • 5.  Progressive dyspnoea  Orthopnoea  Paroxysmal nocturnal dyspnoea  Hemoptysis  Palpitations  Syncope  Nocturnal cough  Chest pain
  • 6.  Cynosis  Clubbing  Persistent distension neck veins  Thrill  Parasternal heave  Diastolic murmur  A grade 3 systolic murmur  AF, persistent arrythmias  Cardiomegaly  Persistent split 2nd sound, Loud P2
  • 7.  Echocardiography ◦ Structural lesion, ◦ Valve area & severity ◦ Valve gradient ◦ Ventricular function  Safe, non invasive  ECG diagnoses arrythmias only
  • 8.  Collapsing pulse – wide pulse pressure in preg  Increase in HR, ectopic beats  JVP waves more prominent  Heart size increases  Apex beat displaced up & laterally  Loud S1,third heart sound  Ejection systolic murmurs(gr 2 & 3)  Venous hums in neck & mammary souffle ov breast  Peripheral edema  ECG – left axis deviation, mild ST changes
  • 9. NYHA Classification Class I Uncompromised/no limitation in physical activity Class II Slight limitation of physical activity/dyspnoea on severe exertion Class III Marked limitation of physical activity/dyspnoea on mild exertion Class IV Severely compromised/Dyspnoea at rest
  • 10.  Myocardial dysfunction(Ejection fraction <40% or cardiomyopathy)  Prior heart failure, arrythmia or stroke  Previous arrythmia needing treatment  NYHA class 3 or 4 or cyanosis  L sided obstruction(mitral area <2sq.cm/peak LV outflow tract gradient above 30mm Hg/Aortic valve <1.5sq cm)
  • 11.  Based on risk stratification  Given intrapartum to women at high & moderate risk only in presence of suspected bacteremia or active infection  Optional in women at high risk undergoing uncomplicated delivery & not for mod risk gp
  • 12. High risk Moderate risk Prosthetic valves Most other congenital cardiac malformations Previous endocarditis Rheumatic valvular heart disease Complex cyanotic heart disease Hypertrophic cardiomyopathy Surgically constructed shunts or conduits Mitral valve prolapse with regurgitation or thickened leaflets
  • 13.  Given 30 – 60 min before the procedure  Ampicillin 2 g or cefazolin/ ceftriaxone 1gm IV  If sensitive to penicillin, clindamycin 600mg IV  Oral – 2gm amoxycillin  Vancomycin also if enterococcus suspected
  • 14.  Isolated atrium septum secondum  Surgical repair of ASD, VSD & PDA  Prev coronory bypass graft surgery  Mitral valve prolapse without regurgitation  Previous Kawasaki disease without valvular dysfunction  Cardiac pacemaker
  • 15.  Eisenmenger syndrome  Primary pulmonary hypertension  Uncorrected severe coarctation  Marfans with aorta dilated >45mm  Severe MS with complications  Severe symptomatic aortic stenosis  Prev peripartum cardiomyopathy with residual LV dysfunction
  • 16.  Preconceptional counselling  V imp in artificial valves on oral anticoagulants  Cong lesions & MS better corrected surgically first  Mild MS, complete family early
  • 17.  Combined clinic, tertiary care centre, cardio+obst  Two issues ◦ ?need for termination ◦ ? Need for surgery ◦ If surgery needed best in 2nd trimester  Fetal surveillance with growth scans
  • 18.  Mostly uneventful  No need of early hospitalisation  Physical activity to be kept within the pt’s cardiac reserve  Adequate rest, frequent follow ups  Look out for nocturnal cough & persistent basal crepitations  heart failure  Sudden reduction in ability to carry out usual duties and dyspnoea  Prevent respiratory infections
  • 19.  Antiobiotics at first sign of infection  Look for asymptomatic bacteriuria & treat  Dental hygiene  Prevent anaemia  Hypertension to be managed incr pre load  Arrythmias to be treated  Fetal echo especially in congenital heart diseased pts
  • 20.  Anaemia  Tachycardia & arrythmias  Hypertension  Hyperthyroidism  Multiple pregnancy  Respiratory infections  Stress
  • 21.  At high risk  Ideally should be pregnant only after surgical correction  If seen in 1st trimester  adv MTP  If continuing preg, counsel regarding risks  Hospitalised for the rest of the pregnancy  Delivery in an experienced unit
  • 22.  Vaginal delivery preferred except ◦ Coarctation of aorta ◦ Marfan’s with aortic diameter 45mm or more  Spontaneous labour best  EAS,Oxytocin, ARM if Cx favourable  PGs theoretical risk of coronary vasospasm & arrythmias
  • 23.  Analgesia  Position - semi recumbent  Fluid management(not more than 75 ml/hr)  Monitoring ◦ BP, Heart rate ◦ Pulse oxymetry ◦ Continuous ECG?arrythmias  ? Swan Ganz catheter in some cases  Continuous electronic fetal heart monitoring
  • 24.  Outlet forceps  Frusemide 40 mg IV soon after baby born THIRD STAGE Ergometrine & Methergin contra indicated Oxytocin IV/IM can be used
  • 25.  Can decompensate  Observed in labour ward 48 hours  Fluid balance to be monitored  Look out for PPH, Infection & Thrombo embolism  Thrombo prophylaxis with heparin  Early ambulation  Lactation
  • 26.  Barrier preferred  LNG IUS(MIRENA) safe & effective  COCs not preferred in pts prone for thrombosis(MS, Artificial valves)  Progesterone injectables & Minipills may be used but fluid retention problem  Vasectomy for male partner  Interval sterilisation GA, not laparoscopic
  • 27.  Congestive cardiac failure  Acute pulmonary edema  Arrythmias  Subacute bacterial endocarditis
  • 28.  Previously, closed mitral valvotomy,  Now, Balloon valvuloplasty, if valve pliable & not calcified & minimal regurgitation  Radiation exposure  Safest time after 20 wks Indications in pregnancy 1. Failure of medical T/T in intractable heart failure 2. Recurrent episodes of ac pulmonary edema
  • 29. Maternal Factors affecting  NYHA functional class  Presence of pulmonary hypertension  Cyanotic heart disease  Type of lesion  Fetal outcome  Prematurity  IUGR  Risk of congenital heart disease
  • 30.  Mitral stenosis  90%  Critical stenosis- valve area <1cm2(N=4cm2)  Moderate stenosis – 1 – 2.5cm2  Mortality high in NYHA class III & IV L atrial presspulm HT ventricular failure,pulm edema  Cardiac surgery best before pregnancy  Or balloon valvuloplasty after 20 wks
  • 31.  Limited physical activity  Na restricted, diuretics,β blockers  If new onset atrial fibrillation – verapamil,electroversion  Digoxin, β blockers for chr fibrillation  If persistant fibrillation/L atrial thrombus – heparin  Vaginal delivery preferred  Epidural analgesia, avoid overload  Bacterial endocarditis prophylaxis
  • 32.  Thromboembolism & infective endocarditis  Warfarin safe for mother but embryopathy ◦ Chondrodysplasia punctata, ◦ Nasal hypoplasia ◦ Optic atrophy ◦ Microcephaly ◦ Miscarriage, IUGR, SB
  • 33.  Discontinue warfarin at 6 wks  In high risk,IV heparin infusion,low risk,SC heparin  Restart warfarin at 14 wks  34 – 36 wks – restart IV heparin infusion  Labour to be planned  Stop heparin 6 hrs before delivery  Restart heparin 6 hrs after vaginal, 12 hrs after CS  Start warfarin after 3days,withdraw heparin once INR adjusted(safe in lactation)  Infective endocarditis prophylaxis mandatory
  • 34.  ASD,corrected VSD, PDA usually safe  Eisenmenger syndrome – preg contraindicated  Tetralogy of Fallot- high risk if uncorrected  Coarctation of aorta – corrected,good prognosis  Residual HT in 30%- risk of aortic dissection & paroxysmal HT in 2ndstage rupture aneurysm,ICH  Marfan’s – risk of aortic dissection & ao rupture  Primary Pulm HT – preg contra indicated
  • 35.  Cardiac failure in the last month of preg or within 5 mths foll delivery.  Absence of another identifiable cause  Absence of recognisable heart disease bef last mth of preg  ECHO – LV systolic dysfunction(EF <45%, M mode fractional shortening < 30% & L V end diastolic dimension > 2.7cm/m2  Mat outcome not very good, pulm embolism, cereb thrombosis
  • 36. 1. What is the intrapartum management of a patient with heart disease in pregnancy? 2. Describe NYHA classification.

Editor's Notes

  1. Risk of pulmonary edema or death higher with even one of these